- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16:39 | INTEGRUM AB: Integrum accelerates Ukraine expansion following landmark decision to expand osseointegration treatment in national healthcare | 2 | Cision News | ||
| 05.03. | Integrum AB: Integrum publishes Interim Report for the third quarter 2025/26 | 144 | GlobeNewswire (Europe) | Mölndal, 5 March 2026 - Integrum (publ) today publishes its interim report for the third quarter 2025/26. During the quarter, the structural transformation was completed and the company now enters the... ► Artikel lesen | |
| INTEGRUM Aktie jetzt für 0€ handeln | |||||
| 03.03. | INTEGRUM AB: Integrum invites to presentation of Q3 2025/26 results | 5 | Cision News | ||
| 11.02. | Integrum AB: Integrum optimizes organization to further accelerate commercialization of OPRA Implant System | 398 | GlobeNewswire (Europe) | Mölndal, Sweden, February 11, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) announces today that the company is implementing organizational changes to accelerate the commercialization... ► Artikel lesen | |
| 02.12.25 | Integrum AB: Integrum's rights issue oversubscribed | 195 | GlobeNewswire (Europe) | Integrum AB (publ) ("Integrum" or the "Company") announced on October 16, 2025 that the Board of Directors had resolved to carry out an issue of shares of series B with preferential right for existing... ► Artikel lesen | |
| 21.11.25 | Integrum AB Q2 Loss Narrows | 2 | RTTNews | ||
| 21.11.25 | Integrum AB: Integrum publishes Interim Report for Q2 2025/26 | 183 | GlobeNewswire (Europe) | Second Quarter 2025/26 (August - October)
Net sales amounted to SEK 22.3 (21.8) million.
Operating result totalled SEK -11.1 (-11.3) million.
Profit/loss after tax amounted to SEK -7.4 (-8.9)... ► Artikel lesen | |
| 19.11.25 | Integrum AB: Invitation to the Second Quarter 2025/26 Results Presentation | 3 | Cision News | ||
| 19.11.25 | True gibt neue Investitionspartnerschaft mit Integrum bekannt, um die Zukunft der Führungskräftevermittlung neu zu definieren | 323 | Business Wire | True, die weltweit führende Plattform für Führungskräfte, die die technologische Entwicklung der Branche durch Daten, KI und Fachwissen vorantreibt, hat heute eine neue strategische Investitionspartnerschaft... ► Artikel lesen | |
| 18.11.25 | INTEGRUM AB: The subscription period in Integrum's rights issue has begun | 1 | Cision News | ||
| 13.11.25 | Integrum AB: Integrum publishes preliminary financial key figures for the second quarter 2025/26 | 189 | GlobeNewswire (Europe) | Mölndal, 13 November 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B), today publishes, in connection with the ongoing rights issue, preliminary and unaudited financial key figures... ► Artikel lesen | |
| 11.11.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 11.11.2025 | 519 | Xetra Newsboard | Das Instrument TE5 SE0009806045 TERRANET AB B EQUITY wird ex Kapitalmassnahme gehandelt am 11.11.2025 The instrument TE5 SE0009806045 TERRANET AB B EQUITY is traded ex capital adjustment on 11.11.2025Das... ► Artikel lesen | |
| 10.11.25 | Integrum AB: Integrum enters into bridge loan agreement to cover short-term working capital needs | 184 | GlobeNewswire (Europe) | Integrum AB (publ) ("Integrum" or the "Company") has today entered into an agreement for a bridge loan of up to SEK 7 million with Buntel AB. The purpose of the loan is to cover the Company's short-term... ► Artikel lesen | |
| 23.10.25 | Integrum AB: Integrum announces organizational restructuring to strengthen its commercial focus | 260 | GlobeNewswire (Europe) | Mölndal, Sweden, October 23, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announced a strategic organizational restructuring to accelerate the commercialization of OPRA... ► Artikel lesen | |
| 20.10.25 | Integrum AB: Integrum announces that the Swedish Securities Council has published a statement regarding the takeover offer for Integrum | 232 | GlobeNewswire (Europe) | Mölndal, Sweden, October 20, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) notes that, in statement 2025:45 dated October 17, 2025, the Swedish Securities Council (Aktiemarknadsnämnden)... ► Artikel lesen | |
| 16.10.25 | Integrum AB: Integrum resolves on a rights issue of shares of series B of approximately SEK 42.6 million subject to approval by extraordinary general meeting and earlier release of Q2 report | 268 | GlobeNewswire (Europe) | The Board of Directors of Integrum AB (publ) ("Integrum" or the "Company") has today resolved to carry out a share issue of approximately SEK 42.6 million before deduction of issue costs with preferential... ► Artikel lesen | |
| 16.10.25 | Integrum AB: Integrum provides operational update ahead of Q2 report | 187 | GlobeNewswire (Europe) | Mölndal, Sweden, October 16, 2025 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today provides an operational update. Following the recent non-completed bid process, Integrum is taking... ► Artikel lesen | |
| 25.09.25 | The observation status for Integrum AB is removed | 273 | GlobeNewswire | On July 22, 2025, the shares in Integrum AB (the "Company") were given observation status with reference to a public takeover offer from OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a... ► Artikel lesen | |
| 01.09.25 | Integrum AB: Stronger positioning paves the way for continued growth | 164 | GlobeNewswire (Europe) | First quarter 2025/26 (May - July)
Net sales amounted to SEK 23.8 (18.5) million.
Operating loss totalled SEK 12.4 (12.0) million.
Profit/loss after tax amounted to SEK -10.0 (-9.4) million.
Earnings... ► Artikel lesen | |
| 22.07.25 | Integrum AB: Statement by the independent bid committee of Integrum AB regarding the public takeover offer from OsteoCentric | 239 | GlobeNewswire (Europe) | The independent bid committee of Integrum AB has decided to recommend that the shareholders of Integrum AB accept OsteoCentric Oncology and Bone Anchored Prostheses, LLC's public takeover offer, based... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 398,45 | +0,56 % | The Silver Tsunami Is Here -- and Intuitive Surgical Could Be the Biggest Winner | ||
| MEDTRONIC | 73,48 | -1,66 % | Future Market Insights: Global Weight Loss and Obesity Management Market | 12.8% CAGR Growth Trajectory | Asia Pacific, North America Lead | Novo Nordisk, Eli Lilly, Medtronic Drive Integrated Care Evolution | NEWARK, Del., April 9, 2026 /PRNewswire/ -- According to the latest analysis by Future Market Insights, the global weight loss and obesity management market is undergoing a transformative... ► Artikel lesen | |
| THERMO FISHER | 448,00 | +0,16 % | TD Cowen lowers Thermo Fisher stock price target on valuation reset | ||
| STRATEC | 18,540 | -1,90 % | STRATEC SE bestätigt ihre fundamentale Stärke | ||
| HIMS & HERS HEALTH | 18,650 | +2,81 % | Hims & Hers-Aktie: Neue Chancen nach dem Hype? | Die Aktie von Hims & Hers Health hat nach einer Zeit voller Hype und überschwänglichen Erwartungen in den vergangenen Monaten massiv gelitten. Nach einem deutlichen Kursrückgang rückt nun die Frage... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 69,22 | +1,05 % | Eurofins Scientific To Divest Electrical & Electronic Testing Business | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Eurofins Scientific SE (EUFI.PA, ERF.PA) announced the signing of an agreement to divest its Electrical & Electronic Testing business, or MET Labs, to UL... ► Artikel lesen | |
| BECTON DICKINSON | 131,55 | -0,38 % | Waters Corporation: Waters Announces CE Mark for Next-Generation Fully Automated BD BACTEC FXI Culture System for Bloodstream Infection Diagnosis | Achieves a ~3-hour faster time to detection (~15% reduction) versus the prior generation system, per clinical study data,¹ enabling earlier targeted therapy.First-of-its-kind blood volume... ► Artikel lesen | |
| FAMICORD | 4,520 | -3,62 % | EQS-Adhoc: FamiCord AG veröffentlicht vorläufige Zahlen für 2025 und Prognose für 2026 | EQS-Ad-hoc: FamiCord AG / Schlagwort(e): Prognose / Gesamtjahr/Geschäftszahlen / Gesamtjahr
FamiCord AG veröffentlicht vorläufige Zahlen für 2025 und Prognose für 2026
15.04.2026... ► Artikel lesen | |
| GERATHERM MEDICAL | 2,870 | +5,90 % | Geratherm Medical wechselt vom Börsensegment Scale in den Open Market | Die Geratherm Medical AG beendet zum 27. April 2026 die Einbeziehung ihrer Aktien in das Börsensegment Scale der Frankfurter Wertpapierbörse und wechselt ins Basic Board am Open Market. Die Börsennotierung... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 54,88 | +1,40 % | Boston Scientific invests $88.4M to expand R&D in Ireland | ||
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB: Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden | EQS-News: SYNLAB
/ Schlagwort(e): Sonstiges
Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden
31.03.2026... ► Artikel lesen | |
| PAUL HARTMANN | 211,00 | +0,48 % | Paul Hartmann: Unterschätzte Medizinaktie | Normalerweise hat die Aktie der in den Bereichen Wundversorgung sowie Inkontinenz tätigen Paul Hartmann AG alles, was es für eine knackige Investmentstory braucht. Mit Erlösen von zuletzt fast 2.450... ► Artikel lesen | |
| RESMED | 196,50 | +0,46 % | RESMED INC: Becoming a substantial holder | ||
| MCKESSON | 729,60 | -0,30 % | ALLZEITHOCH: EchoIQ bei 1$ AUD - der größte Trigger steht unmittelbar bevor | ||
| INMODE | 11,810 | -1,46 % | InMode Ltd.: InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million | YOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen |
INTEGRUM AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +6,28 % bei einem Aktienkurs von 0,643 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INTEGRUM AB finden Sie auf Wallstreet Online.